|By Marketwired .||
|August 21, 2014 03:00 PM EDT||
KALAMAZOO, MI -- (Marketwired) -- 08/21/14 -- Vestaron Corporation, a company that designs environmentally friendly insecticides, announced today a first close on the sale of its Series C Preferred Stock. This $10M round, which was led by new investor Cultivian Sandbox Ventures, a fund specializing in food and agricultural companies, also included major current investors including Southwest Michigan First Life Science Venture Fund, Open Prairie Ventures, Pangaea Ventures, Michigan Accelerator Fund, and others.
"I couldn't be more pleased to welcome Cultivian to the Vestaron team. Their expertise in the agricultural arena will be a great addition to our Board of Directors, and their experience in bringing agricultural products to market will be of tremendous help as we commercialize our first product, a biological insecticide," said John Sorenson, CEO of Vestaron. This product, a naturally occurring peptide, was approved by the EPA for commercial sale in February.
Ron Meeusen, Managing Director of Cultivian Sandbox, said, "We've followed Vestaron for several years now and this is clearly the right time for Cultivian Sandbox to invest in the Company. They have made tremendous technical progress in the past two years, and the commercialization of their first product is exciting indeed."
Vestaron exploits the natural insecticidal properties of a class of peptides which have potent insect killing potential but which are safe to humans, birds, fish, and the environment, including honeybees. These peptides utilize new modes of action that have never been used in insect control, and therefore do not suffer from insect resistance. In addition to the bioinsecticide, the Company is putting the genes for the peptide into crop plants, and is modeling the active sites of the peptides to identify synthetic mimics that also have a favorable safety spectrum.
Chairman of the Board of Directors of Vestaron and Pangaea Ventures General Partner Keith Gillard commented that, "Cultivian Sandbox is a terrific fit for Vestaron and they've come along at the perfect time as we move from a research and development company to a commercial company. Their input into the commercialization process will provide tremendous value as we move the company to the next level."
This press release contains certain "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. Information in this press release, which is not historical, is forward looking and involves a number of risks and uncertainties. Investors are cautioned not to put any undue reliance on any forward-looking statement. Actual results may differ materially from historical results of operations and those discussed in the forward-looking statements for various reasons, including, but not limited to the parties' ability to carry out the business plan, successful development and commercial acceptance of products, ability to fund development necessary for products and for the pursuit of new product opportunities, ability to hire required personnel, the risk of whether products result from development activities, protection of the parties' intellectual property portfolios, the risk associated with obtaining the necessary regulatory approvals, the ability to obtain foreign regulatory approvals for products and to establish marketing arrangements in countries where approval is obtained, and other potential factors.
Dec. 3, 2016 11:00 PM EST Reads: 4,117
Dec. 3, 2016 11:00 PM EST Reads: 938
Dec. 3, 2016 09:30 PM EST Reads: 1,758
Dec. 3, 2016 09:30 PM EST Reads: 1,596
Dec. 3, 2016 08:00 PM EST Reads: 1,742
Dec. 3, 2016 08:00 PM EST Reads: 3,950
Dec. 3, 2016 06:15 PM EST Reads: 1,509
Dec. 3, 2016 05:30 PM EST Reads: 4,040
Dec. 3, 2016 05:15 PM EST Reads: 2,136
Dec. 3, 2016 05:15 PM EST Reads: 1,998
Dec. 3, 2016 04:30 PM EST Reads: 1,472
Dec. 3, 2016 04:00 PM EST Reads: 4,859
Dec. 3, 2016 03:30 PM EST Reads: 1,591
Dec. 3, 2016 03:15 PM EST Reads: 3,222
Dec. 3, 2016 03:00 PM EST Reads: 477